Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments

被引:51
作者
Zeng, FY
Chow, KYC
Hon, CC
Law, KM
Yip, CW
Chan, KH
Peiris, JSM
Leung, FCC
机构
[1] Univ Hong Kong, Dept Zool, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
关键词
SARS; coronavirus; spike glycoprotein; DNA vaccine; neutralizing antibody;
D O I
10.1016/j.bbrc.2004.01.166
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The immunological characteristics of SARS-CoV spike protein were investigated by administering mice with plasmids encoding various S gene fragments. We showed that the secreting forms of S1, S2 subunits and the N-terminus of S I subunit (residues 18-495) were capable of eliciting SARS-CoV specific antibodies and the region immediate to N-terminus of matured S 1 protein contained an important immunogenic determinant for elicitation of SARS-CoV specific antibodies. In addition, mice immunized with plasmids encoding S I fragment developed a Th1-mediated antibody isotype switching. Another interesting finding was that mouse antibodies elicited separately by plasmids encoding S I and S2 subunits cooperatively neutralized SARS-CoV but neither the S I nor S2 specific antibodies did, suggesting the possible role of both S I and S2 subunits in host cell docking and entry. These results provide insights into understanding the immunological characteristics of spike protein and the development of subunit vaccines against SARS-CoV. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1134 / 1139
页数:6
相关论文
共 32 条
[1]  
[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P986
[2]   Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies [J].
Anton, IM ;
Gonzalez, S ;
Bullido, MJ ;
Corsin, M ;
Risco, C ;
Langeveld, JPM ;
Enjuanes, L .
VIRUS RESEARCH, 1996, 46 (1-2) :111-124
[3]   Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E [J].
Bonavia, A ;
Zelus, BD ;
Wentworth, DE ;
Talbot, PJ ;
Holmes, KV .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2530-2538
[4]   The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex [J].
Bosch, BJ ;
van der Zee, R ;
de Haan, CAM ;
Rottier, PJM .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8801-8811
[5]   CORONAVIRUS IBV - VIRUS RETAINING SPIKE GLYCOPOLYPEPTIDE-S2 BUT NOT S1 IS UNABLE TO INDUCE VIRUS-NEUTRALIZING OR HEMAGGLUTINATION-INHIBITING ANTIBODY, OR INDUCE CHICKEN TRACHEAL PROTECTION [J].
CAVANAGH, D ;
DAVIS, PJ ;
DARBYSHIRE, JH ;
PETERS, RW .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :1435-1442
[6]   Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus [J].
Cavanagh, D .
AVIAN PATHOLOGY, 2003, 32 (06) :567-582
[7]  
CHAN KH, 2004, EMERG INFECT DIS SER
[8]   LOCALIZATION OF ANTIGENIC SITES OF THE E2 GLYCOPROTEIN OF TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS [J].
CORREA, I ;
GEBAUER, F ;
BULLIDO, MJ ;
SUNE, C ;
BAAY, MFD ;
ZWAAGSTRA, KA ;
POSTHUMUS, WPA ;
LENSTRA, JA ;
ENJUANES, L .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :271-279
[9]  
DAVIS HL, 2000, DNA VACCINES METHODS, P71
[10]   4 MAJOR ANTIGENIC SITES OF THE CORONAVIRUS TRANSMISSIBLE GASTROENTERITIS VIRUS ARE LOCATED ON THE AMINO-TERMINAL HALF OF SPIKE GLYCOPROTEIN-S [J].
DELMAS, B ;
RASSCHAERT, D ;
GODET, M ;
GELFI, J ;
LAUDE, H .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :1313-1323